Clinical updates, including trial initiations, enrollment status and data readouts and publications: Know Labs, Medalliance, PD Neurotechnology, Shape Memory.

Med-tech firms raising money in public or private financings, including: Encare, Revamp Medical.

New hires and promotions in the med-tech industry, including: Electrocore, Inspira Technologies, Invitae, Nucleai, Olympus, Quibim, Zephyrus.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: ABVC, Accropeutics, Antengene, Bioarctic, Bioray, Celltrion, Hanx, Junshi, Laekna, Pfizer, Pharmabcine.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Biontech, Clover, Daewoong, Hanall, Keyuan Xinhai, Nurron, Pfizer.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Acepodia, Allgenesis, Clarity, Daiichi Sankyo, Geovax, Hanall, Immunos, Immutep, Lynk, Minghui, Mink, Stemcyte.

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Biophytis, BMS, Curium, Gilead, Hutchmed, Inventiva, Ipsen, Novavax, Novo Nordisk, Sino, Takeda.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abiogen, Adcendo, Amplo, Astrivax, Area, Bioray, Bionanosim, Biosenic, BNS Ophthalmics, Concentra, Duality, Effrx, Eli Lilly, Greenlight, Medsenic, Nascent, Nexcella, Oncopeptides, Pharmanovia, Phebra, Philogen, Rafarm, Rain, Roche, Stealth, Sun, Xtalpi.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biophytis, Ferring, Genelux, Oxurion, Profoundbio, Structure, Theseus, TME, Xilio.